What can the clinician do to improve implantation?

被引:23
作者
Boomsma, C. M. [1 ]
Macklon, N. S. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Reprod Med & Gynaecol, Utrecht, Netherlands
关键词
adjuvant therapy; embryo; implantation; IVF;
D O I
10.1016/S1472-6483(10)61034-6
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Implantation is a complicated process that requires the orchestration of a series of events involving both the embryo and the endometrium. Even with the transfer of high quality embryos, implantation rates remain relatively low. The growing tendency towards transferring fewer embryos provides further incentives to improve implantation rates. In this article, the various clinical strategies employed to increase the chance of implantation are reviewed. Embryo transfer technique is a critical step in assisted reproductive technology cycles. Recent studies have shown significant improvements in clinical pregnancy rates resulting from careful embryo transfer technique, appropriate catheter type and placing for embryo transfer. Increasingly, adjuvant pharmaceutical therapies are also being applied with the aim of improving embryo implantation. However, the evidence for their efficacy and safety is limited. Recent evidence suggests that adoption of milder ovarian stimulation regimens may provide a more effective clinical approach to improving implantation, since beneficial effects have been shown for both endometrial receptivity and embryo quality.
引用
收藏
页码:845 / 855
页数:11
相关论文
共 109 条
[1]  
ALINANY GH, 2006, COCHRANE DB SYST REV
[2]   Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial [J].
Andersen, AN ;
Popovic-Todorovic, B ;
Schmidt, KT ;
Loft, A ;
Lindhard, A ;
Hojgaard, A ;
Ziebe, S ;
Hald, F ;
Hauge, B ;
Toft, B .
HUMAN REPRODUCTION, 2002, 17 (02) :357-361
[3]   Successful glucocorticoid treatment for patients with abnormal autoimmunity on in vitro fertilization and embryo transfer [J].
Ando, T ;
Suganuma, N ;
Furuhashi, M ;
Asada, Y ;
Kondo, I ;
Tomoda, Y .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1996, 13 (10) :776-781
[4]  
BAART EB, 2005, HUMAN REPROD, V246, pI91
[5]   Morphometric analysis of peri-implantation endometrium in patients having excessively high oestradiol concentrations after ovarian stimulation [J].
Basir, GS ;
O, WS ;
Ng, EHY ;
Ho, PC .
HUMAN REPRODUCTION, 2001, 16 (03) :435-440
[6]   Adjuvant L-arginine treatment in controlled ovarian hyperstimulation: a double-blind, randomized study [J].
Battaglia, C ;
Regnani, G ;
Marsella, T ;
Facchinetti, F ;
Volpe, A ;
Venturoli, S ;
Flamigni, C .
HUMAN REPRODUCTION, 2002, 17 (03) :659-665
[7]   Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients [J].
Battaglia, C ;
Salvatori, M ;
Maxia, N ;
Petraglia, F ;
Facchinetti, F ;
Volpe, A .
HUMAN REPRODUCTION, 1999, 14 (07) :1690-1697
[8]   Depletion of CD8+ cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile [J].
Blois, SM ;
Joachim, R ;
Kandil, J ;
Margni, R ;
Tometten, M ;
Klapp, BF ;
Arck, PC .
JOURNAL OF IMMUNOLOGY, 2004, 172 (10) :5893-5899
[9]  
BOOMSMA CM, 2006, COCHRANE DB SYST REV
[10]  
Boxmeer JC, 2005, J SOCIAL GYNECOLOGIC, V12, p24A